4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-008562
Options or other derivatives
- Chief Financial Officer acquired 4,881 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-17 | Grant or award : show line 1 in the form Option to purchase common stock | +4,881 | 4,881 | D |
Loading xslF345X05/ownership.xml…